RxSight, Inc. (RXST) Tops Q2 EPS by 19c, beats revenue

RxSight, Inc. (NASDAQ: RXST) reported Q2 EPS of ($0.28), $0.19 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $20.8 million versus the consensus estimate of $19.23 million.

For earnings history and earnings-related data on RxSight, Inc. (RXST) click here.

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Stantec (STN) Tops Q2 EPS by 47c
• RxSight Inc. (RXST) PT Lowered to $7 at Stifel Amid U.S. Adoption Challenges